| | 106.13 | 109.18 | 110.45 | 114.99 |
| Research and Development | | 82.53 | 84.57 | 86.77 | 92.07 |
| Operating Income/Loss | | -106.13 | -109.18 | -110.45 | -114.99 |
| Income/Loss From Continuing Operations Before Tax | | -98.05 | -100.79 | -98.56 | -105.82 |
| Income Tax Expense/Benefit, Current | - | - | - | - | - |
| Income Tax Expense/Benefit, Deferred | - | - | - | - | - |
| Income Tax Expense/Benefit | | 0.19 | 0.01 | 1.54 | - |
| | -98.24 | -100.80 | -100.11 | -105.82 |
| Attributable To Parent | | -98.24 | -100.80 | -100.11 | -105.82 |
| Available To Common Stockholders, Basic | | -98.24 | -100.80 | -100.11 | -105.82 |
| Basic Average Shares | | 617.08 | 611.01 | 9.66 | 588.73 |
| Diluted Average Shares | | 617.08 | 611.01 | 9.66 | 588.73 |
| Basic Earnings Per Share | | -0.16 | -0.16 | -0.17 | -0.18 |
| Diluted Earnings Per Share | | -0.16 | -0.16 | -0.17 | -0.18 |
